Strategies to Diagnose and Treat Endometriosis

Overview

About this study

The purpose of this study is to develop therapeutics targeted to endometriosis lesions, and which can reduce or eliminate the lesions while limiting off-target effects.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Female patients ≥ 18 years of age.
  • Endometriosis samples will be obtained from patients undergoing standard surgical procedure to treat existing disease.

Exclusion Criteria:

  • Males.
  • Female patients < 18 years of age.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/30/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Megan Wasson, D.O.

Open for enrollment

Contact information:

Alexis Baughman

(480) 342-1335

Baughman.Alexis@mayo.edu

More information

Publications

Publications are currently not available